Selective pharmacophore models of dopamine D(1) and D(2) full agonists based on extended pharmacophore features. (Q30384451)

21 June 2017

title

Selective pharmacophore models of dopamine D(1) and D(2) full agonists based on extended pharmacophore features. (English)

1 reference

21 June 2017

1 reference

Marcus Malo

1

1 reference

21 June 2017

Lars Brive

series ordinal

2

1 reference

21 June 2017

Kristina Luthman

series ordinal

3

1 reference

21 June 2017

Peder Svensson

series ordinal

4

1 reference

21 June 2017

publication date

1 February 2010

1 reference

21 June 2017

1 reference

21 June 2017

volume

5

1 reference

21 June 2017

issue

2

1 reference

21 June 2017

page(s)

232-246

1 reference

Resolved monophenolic 2-aminotetralins and 1,2,3,4,4a,5,6,10b-octahydrobenzo[f]quinolines: structural and stereochemical considerations for centrally acting pre- and postsynaptic dopamine-receptor agonists

21 June 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200900398

7 January 2021

Conformational analysis of D1 dopamine receptor agonists: pharmacophore assessment and receptor mapping

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200900398

7 January 2021

Structure-activity relationships for apomorphine congeners. Conformational energies vs. biological activities

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200900398

7 January 2021

Dopamine receptors: molecular biology, biochemistry and behavioural aspects

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200900398

7 January 2021

Dopamine receptor signaling

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200900398

7 January 2021

Apomorphine in the treatment of Parkinson's disease

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200900398

7 January 2021

Proposed dose equivalence for rapid switch between dopamine receptor agonists in Parkinson's disease: a review of the literature

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200900398

7 January 2021

Targeting the dopamine D1 receptor in schizophrenia: insights for cognitive dysfunction

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200900398

7 January 2021

Changes in cortical dopamine D1 receptor binding associated with cognitive training.

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200900398

7 January 2021

Dopaminergic inhibition of adenylate cyclase correlates with high affinity agonist binding to anterior pituitary D2 dopamine receptors

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200900398

7 January 2021

Functional Selectivity and Classical Concepts of Quantitative Pharmacology

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200900398

7 January 2021

Activation of G protein-coupled receptors: beyond two-state models and tertiary conformational changes.

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200900398

7 January 2021

Multiple signaling states of G-protein-coupled receptors

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200900398

7 January 2021

Activation of the beta 2-adrenergic receptor involves disruption of an ionic lock between the cytoplasmic ends of transmembrane segments 3 and 6.

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200900398

7 January 2021

Mechanisms of ligand binding and efficacy at the human D2(short) dopamine receptor

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200900398

7 January 2021

Computer-aided molecular modeling of a D2-agonist dopamine pharmacophore.

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200900398

7 January 2021

trans-2,3-dihydroxy-6a,7,8,12b-tetrahydro-6H-chromeno[3,4-c]isoquinoline: synthesis, resolution, and preliminary pharmacological characterization of a new dopamine D1 receptor full agonist

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200900398

7 January 2021

Further definition of the D1 dopamine receptor pharmacophore: synthesis of trans-6,6a,7,8,9,13b-hexahydro-5H-benzo[d]naphth[2,1-b]azepines as rigid analogues of beta-phenyldopamine

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200900398

7 January 2021

New generation dopaminergic agents. 1. Discovery of a novel scaffold which embraces the D2 agonist pharmacophore. Structure-activity relationships of a series of 2-(aminomethyl)chromans

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200900398

7 January 2021

Comparison of 5-HT1A and dopamine D2 pharmacophores. X-ray structures and affinities of conformationally constrained ligands

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200900398

7 January 2021

Molecular electrostatic potential of D1 and D2 dopamine agonists

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200900398

7 January 2021

CoMFA-based prediction of agonist affinities at recombinant D1 vs D2 dopamine receptors

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200900398

7 January 2021

Differential activation of adenylate cyclase and receptor internalization by novel dopamine D1 receptor agonists

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200900398

7 January 2021

Assays for enhanced activity of low efficacy partial agonists at the D(2) dopamine receptor

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200900398

7 January 2021

Interactions of ligands with active and inactive conformations of the dopamine D2 receptor

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200900398

7 January 2021

Synthesis and dopamine receptor affinities of enantiomers of 2-substituted apomorphines and their N-n-propyl analogues

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200900398

7 January 2021

Synthesis and biological activities of (R)-5,6-dihydro-N,N-dimethyl-4H-imidazo[4,5,1-ij]quinolin-5-amine and its metabolites

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200900398

7 January 2021

Measurement of the proportion of D2 receptors configured in state of high affinity for agonists in vivo: a positron emission tomography study using [11C]N-propyl-norapomorphine and [11C]raclopride in baboons

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200900398

7 January 2021

R and S enantiomers of 11-hydroxy- and 10,11-dihydroxy-N-allylnoraporphine: synthesis and affinity for dopamine receptors in rat brain tissue.

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200900398

7 January 2021

Orally active analogues of the dopaminergic prodrug 6-(N,N-di-n-propylamino)-3,4,5,6,7,8-hexahydro-2H-naphthalen-1-one: synthesis and pharmacological activity

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200900398

7 January 2021

Sumanirole, a highly dopamine D2-selective receptor agonist: in vitro and in vivo pharmacological characterization and efficacy in animal models of Parkinson's disease

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200900398

7 January 2021

Binding characteristics and sensitivity to endogenous dopamine of [11C]-(+)-PHNO, a new agonist radiotracer for imaging the high-affinity state of D2 receptors in vivo using positron emission tomography.

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200900398

7 January 2021

Dopamine receptors labelled by PHNO.

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200900398

7 January 2021

trans-10,11-dihydroxy-5,6,6a,7,8,12b-hexahydrobenzo[a]phenanthridine: a highly potent selective dopamine D1 full agonist

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200900398

7 January 2021

Evaluation of cis- and trans-9- and 11-hydroxy-5,6,6a,7,8,12b-hexahydrobenzo[a]phenanthridines as structurally rigid, selective D1 dopamine receptor ligands

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200900398

7 January 2021

Dihydrexidine, a novel selective high potency full dopamine D-1 receptor agonist

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200900398

7 January 2021

Functional selectivity of dopamine receptor agonists. I. Selective activation of postsynaptic dopamine D2 receptors linked to adenylate cyclase

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200900398

7 January 2021

N-Alkylated 2-aminotetralins: central dopamine-receptor stimulating activity

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200900398

7 January 2021

Structure-activity relationships of dopaminergic 5-hydroxy-2-aminotetralin derivatives with functionalized N-alkyl substituents

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200900398

7 January 2021

Pre- and postsynaptic dopaminergic activities of indolizidine and quinolizidine derivatives of 3-(3-hydroxyphenyl)-N-(n-propyl)piperidine (3-PPP). Further developments of a dopamine receptor model

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200900398

7 January 2021

Dopamine receptors labelled by [3H] quinpirole

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200900398

7 January 2021

Elevation of acetylcholine levels in striatum of rat brain by LY163502, trans-(-)-5,5a,6,7,8,9a,10-octahydro-6-propylpyrimido less than 4,5-g greater than quinolin-2-amine dihydrochloride, a potent and stereospecific dopamine (D2) agonist

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200900398

7 January 2021

Generalized Born Model: Analysis, Refinement, and Applications to Proteins

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200900398

7 January 2021

Molecular Modeling of Geometries, Charge Distributions, and Binding Energies of Small, Drug-Like Molecules Containing Nitrogen Heterocycles and Exocyclic Amino Groups in the Gas Phase and Aqueous Solution

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200900398

7 January 2021

Site-directed mutagenesis of the human dopamine D2 receptor

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200900398

7 January 2021

Effect of multiple serine/alanine mutations in the transmembrane spanning region V of the D2 dopamine receptor on ligand binding

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200900398

7 January 2021

Contributions of Conserved Serine Residues to the Interactions of Ligands with Dopamine D2 Receptors

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200900398

7 January 2021

Contribution of serine residues to constitutive and agonist-induced signaling via the D2S dopamine receptor: evidence for multiple, agonist-specific active conformations

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200900398

7 January 2021

A molecular mechanics approach to the understanding of presynaptic selectivity for centrally acting dopamine receptor agonists of the phenylpiperidine series

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200900398

7 January 2021

(1R,3S)-1-(aminomethyl)-3,4-dihydro-5,6-dihydroxy-3-phenyl-1H-2-benzopyran: a potent and selective D1 agonist

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200900398

7 January 2021

A68930: a potent agonist selective for the dopamine D1 receptor

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200900398

7 January 2021

The second extracellular loop of the dopamine D2 receptor lines the binding-site crevice

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200900398

7 January 2021

Thienopyridine derivatives identified as the first selective, full efficacy, dopamine D1 receptor agonists

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200900398

7 January 2021

https://api.crossref.org/works/10.1002%2FCMDC.200900398

1 reference

7 January 2021

A-77636: a potent and selective dopamine D1 receptor agonist with antiparkinsonian activity in marmosets

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200900398

7 January 2021

Effects of YM 435 and A 77636 on dopamine D-1 receptors in bovine retina in vitro

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200900398

7 January 2021

Dopamine as a novel antimigration and antiproliferative factor of vascular smooth muscle cells through dopamine D1-like receptors

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200900398

7 January 2021

trans-2,6-,3,6- and 4,6-diaza-5,6,6a,7,8,12b-hexahydro-benzo[c]phenanthrene-10,11- diols as dopamine agonists

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200900398

7 January 2021

Dopaminergic benzo[a]phenanthridines: resolution and pharmacological evaluation of the enantiomers of dihydrexidine, the full efficacy D1 dopamine receptor agonist

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200900398

7 January 2021

Structure-activity relationships in the trans-hexahydroindolo[4,3-ab]phenanthridine ("benzergoline") series. 2. Resolution, absolute configuration, and dopaminergic activity of the selective D1 agonist CY 208-243 and its implication for an "extended

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200900398

7 January 2021

Selective and stereospecific interactions of R-SK & F 38393 with [3H]piflutixol but not [3H]spiperone binding to striatal D1 and D2 dopamine receptors: comparisons with SCH 23390

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200900398

7 January 2021

Identifiers

DOI

10.1002/CMDC.200900398

1 reference

21 June 2017

1 reference